Posted on 12/12/18
HealthEC Announces Beaumont ACO as New Client for Population Health Management Solution
EDISON, N.J., Dec. 12, 2018 (GLOBE NEWSWIRE) -- HealthEC, a KLAS-recognized end-to-end provider of Population Health Management (PHM) solutions, announced today that physician-led Beaumont Accountable Care . . .
Posted on 12/12/18
HRS Expands Telehealth Platform to Offer a Three Tier Solution
Health Recovery Solutions (HRS) has expanded their telehealth offerings to include tablet and mobile solutions. The HRS platform now consists of three tiers: PatientConnect Complete, the . . .
Posted on 12/12/18
Synergy Pharmaceuticals Announces Agreement for Bausch Health to Acquire Its Business Assets
Synergy Pharmaceuticals Inc. (NASDAQ: SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies
Posted on 12/12/18
Takeda and the New York Academy of Sciences Announce 2019 Innovators in Science Award Winners
NEW YORK & OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited, (TSE:4502) and the New York Academy of Sciences announced today the Winners of the second annual Innovators . . .
Posted on 12/12/18
Forget the Distractions, Teladoc Health Is a Fantastic Long-Term Buy
Teladoc Health (NYSE:TDOC) isn't the high-flying stock it was earlier this year. After soaring more than 150% year to date as of late September, the telehealth . . .
Posted on 12/12/18
Amicus Therapeutics Awarded United Kingdom Prix Galien Medal for Galafold
CRANBURY, N.J. and LONDON, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a global biotechnology company focused on discovering, developing and delivering novel medicines . . .
Posted on 12/11/18
Biohaven Announces Proposed Public Offering of Common Shares
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a clinical?stage biopharmaceutical company with a portfolio of innovative, late?stage product candidates targeting neurological diseases, including rare disorders, today . . .
Posted on 12/10/18
Daiichi Sankyo and Sarah Cannon Research Institute Launch Strategic Collaboration
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and Sarah Cannon Research Institute announced today a strategic oncology development collaboration. This partnership brings together Daiichi Sankyo's expertise . . .
Posted on 12/10/18
OncoSec Receives $7M Investment From Alpha Holdings
OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a company developing intratumoral cancer immunotherapies, announced today that the Company
Posted on 12/10/18
Elite Pharmaceuticals and SunGen Pharma Receive FDA Approval for Generic Adderall
NORTHVALE, N.J., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB: ELTP) a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, today announced . . .
Posted on 12/10/18
Ardent Health Partners Files For $100 Million IPO
SummaryArdent Health has filed to raise $100 million in a U.S. IPO, although the final figure could be as high as $200 million.Ardent is an acute . . .
Posted on 12/10/18
Better Buy: Intercept Pharmaceuticals vs. Genfit
You might have heard about the "NASH dash" among biopharmaceutical companies. NASH refers to non-alcoholic steatohepatitis, a fatty liver disease that's on track to become the . . .
Posted on 12/9/18
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on December 4, 2018 it approved non-statutory stock options to purchase an aggregate of 48,750 shares of its . . .
Posted on 12/7/18
Celgene Doesn't Want To Be Left Out, Posts Promising JCAR017 Data
SummaryCelgene announces positive preliminary data from its study treating patients with relapsed/refractory chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) using JCAR017.A key risk is . . .
Posted on 12/6/18
Can Celgene and bluebird bio Survive a Two-Pronged Attack?
Around this time last year, investors were thrilled with bluebird bio (NASDAQ:BLUE), and a next-generation cancer therapy that the pre-commercial biotech is developing in partnership with . . .
Posted on 12/6/18
Johnson & Johnson (JNJ) Management Presents at Citi's 2018 Global Healthcare Conference (Transcript)
Johnson & Johnson (NYSE:JNJ) Citi's 2018 Global Healthcare Conference December 5, 2018 10:15 AM ETExecutivesMatt Stuckley - IRJoe Wolk - EVP and CFOAnalystsAmit Hazan - CitiAndrew . . .
Posted on 12/5/18
Better Buy: Intuitive Surgical vs. Johnson & Johnson
Nearly 10,000 baby boomers turn 65 every day, a trend expected to persist until 2029. Considering that age and healthcare costs are positively correlated, it's natural . . .
Posted on 12/4/18
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
BRIDGEWATER, N.J., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious . . .
Posted on 12/4/18
Carnot BioSciences to Develop Protein-Based Therapeutics for Rare Metabolic Diseases
NEW YORK & CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--SmartZyme BioPharma, an OrbiMed Advisors portfolio company, and Hemoshear Therapeutics today announced a strategic agreement to develop novel protein-based therapeutics to . . .
Posted on 12/4/18
Craft Capital Management Closes 10M Dollar Transaction in Variant Pharmaceuticals
Garden City, NY based Brokerage firm Craft Capital Management is excited to announce they have secured and closed a 10 million dollar investment in Variant Pharmaceuticals, . . .
Posted on 12/3/18
NYCEDC Grants $1M To Quentis Therapeutics For Expansion of LifeSci Space in West Harlem
First grant to be distributed from $10M LifeSci NYC Expansion FundNew York City Economic Development Corporation (NYCEDC) and Quentis Therapeutics(Quentis), a New York City based biotechnology . . .
Posted on 12/3/18
Nestlé Health Science Celebrates Inauguration of Global R&D Center in New Jersey
Nestlé Health Science today celebrated the inauguration of its new Nestlé Product Technology Center with a ribbon cutting ceremony at the facility in Bridgewater, N.J. The . . .
Posted on 12/3/18
Alteogen and Lynkogen Expand Agreement
DAEJEON, South Korea & EAST WINDSOR, N.J.--(BUSINESS WIRE)--Alteogen Inc. (196170.KQ) and Lynkogen Inc. today announced that they have expanded the scope of their exclusive option agreement. . . .
Posted on 12/3/18
Topix Pharmaceuticals Launches Professional In-Office Peels
Topix Pharmaceuticals, Inc. announces the launch of Topix Professional Peels, with a configurable peel portfolio that allows providers the flexibility to choose specific peel ingredients and . . .
Posted on 12/3/18
Tactiva Therapeutics Secures $35 Million Series A Financing
Tactiva Therapeutics, development stage immuno-oncology company with a unique approach to adoptive T-cell therapy, announced today it has secured a $35 million

